Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AEGON LTD. Regulatory Filings 2021

Apr 2, 2021

30489_rns_2021-04-02_cc663ffe-3170-4e90-8408-de31ee519c4f.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

IRANNOTICE 1 d169925dirannotice.htm IRANNOTICE IRANNOTICE

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

USA

Handled by The Hague
J.O. van Klinken April 1, 2021

Re: Notice of disclosure filed in Securities Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act

Ladies and Gentlemen:

Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Aegon N.V. has made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on March 18, 2021. The disclosure can be found under the heading “Compliance with regulations” in the Annual Report on Form 20-F and is incorporated by reference herein.

Sincerely,
/s/ J.O. van Klinken
J.O. van Klinken
General Counsel